159 related articles for article (PubMed ID: 17273766)
1. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers.
Marcus KJ; Astrakas LG; Zurakowski D; Zarifi MK; Mintzopoulos D; Poussaint TY; Anthony DC; De Girolami U; Black PM; Tarbell NJ; Tzika AA
Int J Oncol; 2007 Mar; 30(3):651-7. PubMed ID: 17273766
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
[TBL] [Abstract][Full Text] [Related]
3. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM
Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
6. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric MR assessment of pediatric brain tumors.
Tzika AA; Astrakas LG; Zarifi MK; Petridou N; Young-Poussaint T; Goumnerova L; Zurakowski D; Anthony DC; Black PM
Neuroradiology; 2003 Jan; 45(1):1-10. PubMed ID: 12525947
[TBL] [Abstract][Full Text] [Related]
8. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
9. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
Warren KE; Frank JA; Black JL; Hill RS; Duyn JH; Aikin AA; Lewis BK; Adamson PC; Balis FM
J Clin Oncol; 2000 Mar; 18(5):1020-6. PubMed ID: 10694552
[TBL] [Abstract][Full Text] [Related]
11. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
12. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
13. Prospective longitudinal proton magnetic resonance spectroscopic imaging in adult traumatic brain injury.
Holshouser BA; Tong KA; Ashwal S; Oyoyo U; Ghamsary M; Saunders D; Shutter L
J Magn Reson Imaging; 2006 Jul; 24(1):33-40. PubMed ID: 16755529
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy imaging in the study of human brain cancer.
Martínez-Bisbal MC; Celda B
Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):618-30. PubMed ID: 20016453
[TBL] [Abstract][Full Text] [Related]
16. Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.
Zakian KL; Shukla-Dave A; Meyers P; Gorlick R; Healey J; Thaler HT; Huvos AG; Panicek DM; Koutcher JA
Cancer Res; 2003 Dec; 63(24):9042-7. PubMed ID: 14695223
[TBL] [Abstract][Full Text] [Related]
17. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy in school-aged autistic children.
Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopy improves outcome prediction in perinatal CNS insults.
Kadri M; Shu S; Holshouser B; Deming D; Hopper A; Peverini R; Ashwal S
J Perinatol; 2003; 23(3):181-5. PubMed ID: 12732853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
